NorstellaLinQ: Gain Real-Time Insights on High-Risk Patient Populations with Real-World Data
In this use case, find out how MMIT, using NorstellaLinQ, used real-world data to help a manufacturer specializing in multiple myeloma therapies get a clearer picture of high-risk patients and the physicians treating them.
Identify newly diagnosed and relapsed high-risk patients using genomic and EMR data.
Improve outreach to healthcare providers likely to treat these specific patient populations.
Generate actionable alerts to engage HCPs and guide critical treatment conversations.